Evaluation of the performance of biological drugs in the treatment of ankylosing spondylitis: cohort study, Minas Gerais, 2018-2023
The analysis of persistence and time to discontinuation showed no differences between the drugs, which justified their maintenance in the first line of treatment of the protocol. Factors associated with the clinical profile of users may be related to differences in effectiveness, but more in-depth studies are needed to confirm these results, given the limitations of using administrative data in epidemiological research.
Authors
- Jones Santos (ORCID: https://orcid.org/0000-0002-5685-1678)
- Gerusa Oliveira (ORCID: https://orcid.org/0000-0002-6777-8912)
- Bárbara Rodrigues Alvernaz dos Santos (ORCID: https://orcid.org/0000-0001-9796-4321)
Institutions
- Universidade Federal de Minas Gerais (BR)
- Universidade Federal do Espírito Santo (BR)
Publication Details
- Journal
- Epidemiologia e Serviços de Saúde
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1590/s2237-96222025v34e20240116.en
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00